(Q33723084)

28 July 2017

title

Development of HBsAg-binding aptamers that bind HepG2.2.15 cells via HBV surface antigen (English)

1 reference

28 July 2017

Jia Liu

1

1 reference

28 July 2017

Yan Yang

2

1 reference

28 July 2017

Bin Hu

3

1 reference

28 July 2017

Zhi-yong Ma

4

1 reference

28 July 2017

Hong-ping Huang

5

1 reference

28 July 2017

Yuan Yu

6

1 reference

28 July 2017

Shen-pei Liu

7

1 reference

28 July 2017

Meng-ji Lu

8

1 reference

28 July 2017

Dong-liang Yang

9

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20960281

6 August 2024

publication date

12 February 2010

1 reference

full work available at URL

28 July 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227915

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960281

https://europepmc.org/articles/PMC8227915

6 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960281

https://europepmc.org/articles/PMC8227915?pdf=render

6 August 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960281

https://doi.org/10.1007/s12250-010-3091-7

6 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20960281

http://link.springer.com/content/pdf/10.1007/s12250-010-3091-7.pdf

6 August 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S12250-010-3091-7

http://link.springer.com/article/10.1007/s12250-010-3091-7/fulltext.html

6 August 2024

1 reference

https://api.crossref.org/works/10.1007/S12250-010-3091-7

http://link.springer.com/content/pdf/10.1007/s12250-010-3091-7

6 August 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12250-010-3091-7

6 August 2024

1 reference

28 July 2017

volume

25

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

27-35

1 reference

Pegaptanib: a novel approach to ocular neovascularization

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3091-7

Oligonucleotide inhibitors of P-selectin-dependent neutrophil-platelet adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3091-7

Hepatitis B virus infection: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3091-7

Anti-L-selectin aptamers: binding characteristics, pharmacokinetic parameters, and activity against an intravascular target in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-010-3091-7

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

12 December 2020

Escort aptamers: a delivery service for diagnosis and therapy

1 reference

12 December 2020

Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor

1 reference

12 December 2020

Immune electron microscopic study of hepatitis B virus associated antigens in hepatocytes.

1 reference

12 December 2020

High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I.

1 reference

12 December 2020

Selection of single-stranded DNA molecules that bind and inhibit human thrombin

1 reference

12 December 2020

Treatment of chronic hepatitis B

1 reference

12 December 2020

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

1 reference

12 December 2020

A review of entecavir in the treatment of chronic hepatitis B infection

1 reference

12 December 2020

Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections

1 reference

12 December 2020

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

1 reference

12 December 2020

A viral RNA that binds ATP and contains a motif similar to an ATP-binding aptamer from SELEX.

1 reference

12 December 2020

Aptamer mediated siRNA delivery

1 reference

12 December 2020

Treatment of chronic hepatitis B infection using interferon

1 reference

12 December 2020

Interaction of lymphocytes with hepatocytes containing hepatitis B antigen: ultrastructural demonstration of target antigen and T-cell subsets by the peroxidase antibody technique

1 reference

12 December 2020

Current treatment of chronic hepatitis B: benefits and limitations

1 reference

12 December 2020

Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

1 reference

12 December 2020

Dissecting protein:protein interactions between transcription factors with an RNA aptamer

1 reference

12 December 2020

RNA aptamers as reversible antagonists of coagulation factor IXa.

1 reference

12 December 2020

Potent 2'-amino-, and 2'-fluoro-2'-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor

1 reference

12 December 2020

Looking to the future: new agents for chronic hepatitis B.

1 reference

12 December 2020

Aptamers as therapeutic and diagnostic agents

1 reference

12 December 2020

Current treatment and future directions in the management of chronic hepatitis B viral infection

1 reference

12 December 2020

Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology

1 reference

12 December 2020

Three small ribooligonucleotides with specific arginine sites

1 reference

12 December 2020

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

1 reference

12 December 2020

The generation and characterisation of antagonist RNA aptamers to MCP-1

1 reference

12 December 2020

Tenascin-C aptamers are generated using tumor cells and purified protein

1 reference

12 December 2020

Introduction to chronic hepatitis B infection

1 reference

12 December 2020

The generation and characterization of antagonist RNA aptamers to human oncostatin M

1 reference

12 December 2020

Hepatitis B surface antigen specific cytotoxic T lymphocyte activity in hepatitis B virus infection

1 reference

12 December 2020

Aptamers: an emerging class of molecules that rival antibodies in diagnostics

1 reference

12 December 2020

In vitro selection of RNA molecules that bind specific ligands

1 reference

12 December 2020

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20960281

6 August 2024

1 reference